A clinical appraisal of flucloxacillin in the management of skin and soft tissue infections in Nigeria.
The resolution of skin and soft tissue infections following a single course of treatment with flucloxacillin was assessed in 235 patients recruited by nineteen physicians. In all, 88.5% of patients were completely cured or showed a highly satisfactory improvement after 3 to 12 days' treatment. Only three patients failed to show any improvement at all. Side-effects were limited to twelve patients (5.1%) all of whom were able to complete their course of treatment.
D000038:Abscess / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000188:drug therapy*; D002270:Carbuncle / Q000188:drug therapy; D002481:Cellulitis / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003023:Cloxacillin / Q000031:analogs & derivatives*; D005260:Female; D005334:Fever / Q000188:drug therapy; D005436:Floxacillin / Q000009:adverse effects / Q000627:therapeutic use*; D005667:Furunculosis / Q000188:drug therapy; D006801:Humans; D007169:Impetigo / Q000188:drug therapy; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D009549:Nigeria; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D005436:Floxacillin; D003023:Cloxacillin